Lawmaker Asks GAO to Investigate TrumpRx Drug Savings Claims

TL;DR

• A member of the House has requested a federal review of TrumpRx.
• The request goes to the Government Accountability Office (GAO).
• The review would examine whether the platform has actually lowered drug costs for Americans.
• No findings have been released yet; this is only a request for investigation.

Why It Matters

The scrutiny of TrumpRx centers on transparency in U.S. drug pricing policy, an issue that affects millions of consumers, including Indian-American families who rely on the American healthcare system for prescription medications.